Dr. J Brent Muhlestein, MD

Dr. Muhlestein practices at Intermountain Medical Center in Murray, Utah, part of Intermountain Health.

Dr. Muhlestein's NPI, 1689683435, was assigned on August 7, 2006. Dr. Muhlestein graduated from University of Utah School of Medicine in 1984. Dr. Muhlestein holds Utah license 1878711205.

Dr. Muhlestein's primary practice is Intermountain Medical Center, at 5121 South Cottonwood Street, Murray, UT 84107 in Salt Lake County. The practice phone is (801) 507-7000.

Dr. Muhlestein's primary practice is Intermountain Medical Center in Murray, Utah, part of Intermountain Health. Dr. Muhlestein is also affiliated with University of Utah Hospital. The medical group on file is Intermountain Health. Dmand AI also links Dr. Muhlestein to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muhlestein practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Muhlestein's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Muhlestein is licensed in Utah.

CMS data shows 365 Medicare services from Dr. Muhlestein across 4 procedure codes in 2024, for 215 Medicare patients. Medicare paid $24,119 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 215 Medicare patients who saw Dr. Muhlestein in 2024. The largest group is 75 to 84, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Muhlestein's median patient age at 75, with 44% women.

In 2024, Dr. Muhlestein wrote 505 Medicare Part D claims for 176 patients. 76% of them were for generic drugs. CMS names the drug for 280 of them, across 15 drugs with 11 or more claims each, at $89,976 in total drug cost. In 2023, CMS named 350 claims across 16 drugs.

Dr. Muhlestein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Muhlestein, published from 2012 to 2025. 2013 was the busiest year, with 4. The most frequent topics are American Heart Association, Atrial Fibrillation and Cardiology. Dr. Muhlestein's most frequent co-authors are Jeffrey L. Anderson, MD, Thomas M. Bashore, MD and Ralph G. Brindis, MD.

Dmand AI links Dr. Muhlestein to 2 clinical trials, 2 of them phase 4 studies. 1 is still active or recruiting. Conditions studied include Cognitive Dysfunction, Hypertriglyceridemia and Cognition Disorders.

CMS Open Payments shows 72 general payments to Dr. Muhlestein from 18 drug and device companies from 2016 to 2025. Grants make up the largest share, 73% of the total. Medtronic Vascular, Inc. paid the most, $50,151. It also lists 4 research payments totaling $8,196 from 2019 to 2025.

Dr. Muhlestein graduated from University of Utah School of Medicine in 1984.